Brussels, Belgium

Yohei Hayashi

This inventor holds 2 USPTO granted patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2018-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yohei Hayashi. Retrieved from https://idiyas.com/inventor/yohei-hayashi-3bwh6kbr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yohei Hayashi: Innovator in Antibacterial Compounds

Introduction

Yohei Hayashi is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating tuberculosis. With a total of two patents to his name, Hayashi's work is recognized for its potential impact on public health.

Latest Patents

Hayashi's latest patents focus on heterobicyclic compounds and their use for the treatment of tuberculosis. The primary objective of these inventions is to provide compounds that exhibit excellent antibacterial activity against tuberculosis bacteria, multidrug-resistant tuberculosis bacteria, and non-tuberculous mycobacteria. The compounds are described by a general formula, with each symbol defined in the attached specifications, or as a salt thereof.

Career Highlights

Hayashi is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the field of medicine. His work is crucial in the ongoing battle against tuberculosis, a disease that remains a significant global health challenge.

Collaborations

Some of his notable coworkers include Hiroshi Shimizu and Yoshikazu Kawano, who contribute to the collaborative efforts in research and development at Otsuka Pharmaceutical Company.

Conclusion

Yohei Hayashi's contributions to the field of antibacterial compounds highlight his commitment to improving health outcomes for those affected by tuberculosis. His innovative work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…